4.8 Article

Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer

Journal

EMBO JOURNAL
Volume 32, Issue 12, Pages 1665-1680

Publisher

WILEY
DOI: 10.1038/emboj.2013.99

Keywords

androgen; non-coding RNA; prostate cancer

Funding

  1. Grants of the Cell Innovation Program
  2. MEXT, Japan
  3. JSPS, Japan
  4. MHLW, Japan
  5. Program for Promotion of Fundamental Studies in Health Sciences, NIBIO, Japan
  6. Grants-in-Aid for Scientific Research [23249040, 25293214] Funding Source: KAKEN

Ask authors/readers for more resources

High-throughput techniques have identified numerous antisense (AS) transcripts and long non-coding RNAs (ncRNAs). However, their significance in cancer biology remains largely unknown. Here, we report an androgen-responsive long ncRNA, CTBP1-AS, located in the AS region of C-terminal binding protein 1 (CTBP1), which is a corepressor for androgen receptor. CTBP1-AS is predominantly localized in the nucleus and its expression is generally upregulated in prostate cancer. CTBP1-AS promotes both hormone-dependent and castration-resistant tumour growth. Mechanistically, CTBP1-AS directly represses CTBP1 expression by recruiting the RNA-binding transcriptional repressor PSF together with histone deacetylases. CTBP1-AS also exhibits global androgen-dependent functions by inhibiting tumour-suppressor genes via the PSF-dependent mechanism thus promoting cell cycle progression. Our findings provide new insights into the functions of ncRNAs that directly contribute to prostate cancer progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available